SCHEMBL18361827

SCHEMBL18361827

CCCCOc1cccc2c1ccn2C1COC1

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ LOXL2 Q9Y4K0 1/20 0.53
▸ CYP1A2 P05177 1/20 0.37
▸ CYP2C9 P11712 1/20 0.37
▸ CYP2C19 P33261 1/20 0.37
▸ PIK3CB P42338 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.36
▸ TSHR P16473 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ HTR1B P28222 2/20 0.36
▸ RORA P35398 1/20 0.36
▸ NR5A1 Q13285 1/20 0.36
▸ PPARG P37231 3/20 0.35
▸ PPARA Q07869 3/20 0.35
▸ PPARD Q03181 2/20 0.35
▸ HTR6 P50406 3/20 0.35
▸ HTR1D P28221 1/20 0.34
▸ MCHR1 Q99705 1/20 0.34
▸ CYP2A6 P11509 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20337958 0.80 LOXL2 (0.53) LOXL2L3MBTL1HTR6
SCHEMBL18362160 0.74 HTR6 (0.48) CYP1A2CYP2C9CYP2C19PPARGPPARA
SCHEMBL8459745 0.72 CYP1A2 (0.42) CYP1A2CYP2C9CYP2C19ALDH1A1TSHR
SCHEMBL6625887 0.71 HTR1B (0.43) CYP1A2CYP2C9CYP2C19ALDH1A1TSHR
SCHEMBL19089432 0.70 RHEB (0.50) CYP1A2CYP2C9CYP2C19HTR1BHTR6
SCHEMBL20655543 0.69 GRM2 (0.42) CYP2C9HTR1BPPARGPPARAPPARD
SCHEMBL18361826 0.69 LOXL2 (1.00) LOXL2
SCHEMBL20655557 0.69 HTR6 (0.46) PPARGPPARAPPARDHTR6MCHR1
SCHEMBL18069184 0.68 HTR6 (0.69) CYP1A2CYP2C9CYP2C19TSHRPPARG
SCHEMBL30503960 0.68 CYP2C9 (0.59) CYP1A2CYP2C9CYP2C19L3MBTL1HTR1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017003862-A1 LYSYL OXIDASE-LIKE 2 INHIBITORS AND USES THEREOF PHARMAKEA, INC. (US) 2017-01-05 — — WO disclosed
Send feedback